Bajoka Adamson Sirijatuphat, P. Koomanachai, V. Thamlikitkul; Siriraj Hosp., Bangkok, Thailand. M. Gillis, M. H. Nguyen, C. J. Clancy, R. K. Shields; Univ. of Pittsburgh, Pittsburgh, PA.

159 TUESDAY SCIENTIFIC SESSIONS Final Program K-1595 Mupirocin Resistance in Methicillin-Resistant Staphylococcus aureus MRSA in Singapore General Hospital SGH Burns Unit BU J. Teo, A. L. Kwa, W. Lee, Y. Liew, T. H. Koh, S. S. Goh, M. L. Ling, C. Song, M. P. Chlebicki; Singapore Gen. Hosp., Sg, Singapore. K-1596 A Neonatal MRSA Outbreak Investigation Using Rapid Whole Genome Sequencing Withdrawn K-1597 End Stage Renal Disease ESRD Patients with Methicillin- Resistant Staphylococcus aureus MRSA Bacteremia Show No Increased Risk for Clinical Failure

B. Bajoka

1 , S. Arshad 2 , D. Moreno 2 , A. Shoyinka 2 , M. J. Zervos 2,3 ; 1 Michi- gan State Univ., Sch. of Med., Lansing, MI, 2 Henry Ford Hosp., Detroit, MI, 3 Wayne State Univ., Sch. of Med., Detroit, MI. K-1598 Clinical Response at Day 3 of Initial Antibiotic Treatment in Hospitalized Adult Patients with Acute Bacterial Skin and Skin Structure Infections: A Patient Chart Review Study within a US Healthcare System

R. Adamson

1 , I. Lew 1 , S. Amara 1 , X. Huang 2 ; 1 Barnabas Health, South Plainfield, NJ, 2 Forest Res. Inst., Jersey City, NJ. K-1599 Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in a Neonatal Intensive Care Unit in Japan M. Nagao, M. Kawai, G. Hotta, M. Yamamoto, Y. Matsumura, A. Matsushima, Y. Ito, S. Takakura, S. Ichiyama; Kyoto Univ. Hosp., Kyoto, Japan. K-1600 Comparative Epidemiology of Bacteremia Due to Methicillin- Resistant Staphylococcus aureus MRSA Between Older and Younger Adults: A Propensity Score Analysis

R. Kullar

1 , M. J. Rybak 2 , K. S. Kaye 3 ; 1 Wayne State Univ., Detroit, MI, 2 Wayne State Univ., Anti-Infective Res. Lab., Detroit, MI, 3 Detroit Med. Ctr.Wayne State Univ., Detroit, MI. K-1601 Age and Pitt Score Predict Early Death in Methicillin- Resistant Staphylococcus aureus MRSA Bacteremia

V. P. Martins

1 , D. Otero 1,2 , A. L. Ferreira 1 , A. G. Magalhães 1 , L. A. Mascarenhas 1,2 , F. L. Cardoso 1 , S. A. Nouér 1 ; 1 Univ. Federal do Rio de Janeiro, Rio de Janeiro, Brazil, 2 Inst. Natl. do Cancer, Rio de Janeiro, Brazil. ------------------------------------------------------------------------ 183 K Poster Session Resistant Acinetobacter Infections Tuesday, 11:15 a.m.–1:15 p.m. . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: K-1602 Randomized Controlled Trial of Colistin COL vs. Colistin plus Fosfomycin COL + FOS for Infections Caused by Carbape- nem-Resistant CR Acinetobacter baumannii

R. Sirijatuphat, P. Koomanachai, V. Thamlikitkul; Siriraj Hosp., Bangkok, Thailand.

K-1603 Carbapenem-Resistant A. baumannii Bacteremia in Oncologic Intensive Care Unit E. Abdala, L. P. G. Duarte, M. P. Freire, K. Y. Ibrahim, A. S. K. Magri, C. P. Garcia, L. C. Pierrotti, P. P. Gutierrez, F. Rossi, M. Bellesso, J. Pereira, L. A. Hajjar, P. M. Hoff; Inst. do Câncer do Estado de São Paulo da FMUSP, São Paulo, Brazil. K-1604 Patients Infected with Acinetobacter baumannii and Treated with Tigecycline: The Impact of Minimal Inhibitory Concentration MIC on Outcomes and the Role of Different Testing Methods K. Hayakawa, D. Marchaim, P. Bathina, D. R. Abbadi, J. M. Pogue, A. Bhargava, P. R. Lephart, K. S. Kaye; Detroit Med. Ctr. DMC, Wayne State Univ., Detroit, MI, Detroit, MI. K-1605 Predictors of Treatment Failure in Patients Infected with Resistant Acinetobacter baumannii Ab Treated with Colistin COL Plus Doripenem DOR

L. M. Gillis, M. H. Nguyen, C. J. Clancy, R. K. Shields; Univ. of Pittsburgh, Pittsburgh, PA.

K-1606 Carbapenem-Resistant Strains of Acinetobacter baumannii Isolated from an Intensive Care Unit in Brazil: The Importance of OXA-143 and OXA-23 F. C. Neves 1 , W. T. Clemente 1 , N. Lincopan 2 , R. Romanelli 1 , L. F. Paiva 1 , L. A. Jesus 1 , V. Nobre 1 ; 1 Univ. Federal de Minas Gerais, Belo Horizonte, Brazil, 2 Univ. de São Paulo, São Paulo, Brazil. K-1607 Colistin with Carbapenem to Treat Extensively Drug Resis- tant A. baumannii XDRAB Bacteremia Achieved Better Micro- biological Outcomes Than Colistin with Tigecycline

A. Cheng